These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7791543)

  • 21. Comparative subcellular distribution of benzaldehyde and acetaldehyde dehydrogenase activities in two hepatoma cell lines and in normal hepatocytes.
    Ferro M; Muzio G; Bassi AM; Biocca ME; Canuto RA
    Cell Biochem Funct; 1991 Jul; 9(3):149-54. PubMed ID: 1661206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldehyde dehydrogenase as a marker for chemically initiated mouse liver tumors.
    Richmond RE; Pereira MA
    Cancer Lett; 1986 May; 31(2):205-11. PubMed ID: 3697964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in aldehyde dehydrogenase occurring during rat hepatocarcinogenesis induced by ethionine combined with dietary choline deficiency.
    Evces S; Lindahl R
    Cancer Res; 1986 Jul; 46(7):3587-92. PubMed ID: 2871926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of phenobarbital and 3-methylcholanthrene on aldehyde dehydrogenase activity in cultures of HepG2 cells and normal human hepatocytes.
    Marselos M; Strom SC; Michalopoulos G
    Chem Biol Interact; 1987; 62(1):75-88. PubMed ID: 3034438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcellular localization of aldehyde dehydrogenase isozymes in human liver.
    Takase S; Tsutsumi M; Takada A
    Gastroenterol Jpn; 1989 Feb; 24(1):31-9. PubMed ID: 2707550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis.
    Park YM; Choi JY; Byun BH; Cho CH; Kim HS; Kim BS
    Exp Mol Med; 1998 Mar; 30(1):35-40. PubMed ID: 9873820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics and aldehyde dehydrogenase activity of four rat hepatoma cell lines produced by diethylnitrosamine-phenobarbital treatment.
    Lin KH; Leach MF; Winters AL; Lindahl R
    In Vitro Cell Dev Biol; 1986 May; 22(5):263-72. PubMed ID: 2872200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substrate preference of a cytosolic aldehyde dehydrogenase inducible in rat liver by treatment with 3-methylcholanthrene.
    Marselos M; Lindahl R
    Toxicol Appl Pharmacol; 1988 Sep; 95(2):339-45. PubMed ID: 3420620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histochemical localization of aldehyde dehydrogenase during rat hepatocarcinogenesis.
    Lindahl R; Clark R; Evces S
    Cancer Res; 1983 Dec; 43(12 Pt 1):5972-7. PubMed ID: 6196110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implications of telomerase activity in resected hepatocellular carcinoma.
    Kanamaru T; Yamamoto M; Morita Y; Itoh T; Kuroda Y; Hisatomi H
    Int J Mol Med; 1999 Sep; 4(3):267-71. PubMed ID: 10425277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aromatic aldehydes as fluorogenic indicators for human aldehyde dehydrogenases and oxidases: substrate and isozyme specificity.
    Wroczyński P; Wierzchowski J
    Analyst; 2000 Mar; 125(3):511-6. PubMed ID: 10829347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Major Intestinal Catabolite of Quercetin Glycosides, 3-Hydroxyphenylacetic Acid, Protects the Hepatocytes from the Acetaldehyde-Induced Cytotoxicity through the Enhancement of the Total Aldehyde Dehydrogenase Activity.
    Liu Y; Myojin T; Li K; Kurita A; Seto M; Motoyama A; Liu X; Satoh A; Munemasa S; Murata Y; Nakamura T; Nakamura Y
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydropyrimidine dehydrogenase activity of cancerous and non-cancerous tissues in liver and large intestine.
    Ikeguchi M; Hirooka Y; Makino M; Kaibara N
    Oncol Rep; 2001; 8(3):621-5. PubMed ID: 11295091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in aldehyde dehydrogenase activity during diethylnitrosamine-initiated rat hepatocarcinogenesis.
    Lindahl R; Evces S
    Carcinogenesis; 1987 Jun; 8(6):785-90. PubMed ID: 3608075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma associated with alcoholic liver disease: a clinicopathological study and genetic polymorphism of aldehyde dehydrogenase 2.
    Ohhira M; Fujimoto Y; Matsumoto A; Ohtake T; Ono M; Kohgo Y
    Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):378A-382A. PubMed ID: 8986242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical genetic analysis of human and rodent aldehyde dehydrogenase (ALDH).
    Hopkinson DA; Santisteban I; Povey S; Smith M
    Alcohol; 1985; 2(1):73-8. PubMed ID: 4015840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and partial characterization of a variant form of cytosolic aldehyde dehydrogenase isozyme.
    Eckey R; Agarwal DP; Saha N; Goedde HW
    Hum Genet; 1986 Jan; 72(1):95-7. PubMed ID: 3943866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of aldehyde dehydrogenase isozyme activity in human liver.
    Sugata K; Takada A; Takase S; Tsutsumi M
    Alcohol; 1988; 5(1):39-43. PubMed ID: 3355667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary structure of human hepatocellular carcinoma-associated aldehyde dehydrogenase.
    Satomichi A; Nakajima Y; Takeuchi A; Takagaki Y; Saigenji K; Shibuya A
    Biochim Biophys Acta; 2000 Sep; 1481(2):328-36. PubMed ID: 11018724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver cell atypias: a comparative study in cirrhosis with and without hepatocellular carcinoma.
    Ojanguren I; Castellà E; Ariza A; Santos J; Planas R; Bruguera M
    Histopathology; 1997 Feb; 30(2):106-12. PubMed ID: 9067732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.